Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 5.3.2.1 - phenylpyruvate tautomerase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acquired Immunodeficiency Syndrome
Red blood cells: The primary reservoir of macrophage migration inhibitory factor in whole blood.
ACTH-Secreting Pituitary Adenoma
Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Acute Coronary Syndrome
Association between the -794 (CATT)5-8??MIF gene polymorphism and susceptibility to acute coronary syndrome in a western Mexican population.
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease.
Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.
Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
Acute Kidney Injury
Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study.
Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury.
The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery.
The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
Uropathogenic Escherichia coli causes cortical tubular necrotic cell death and the release of macrophage migration inhibitory factor.
Acute Lung Injury
Age-dependent alterations in the inflammatory response to pulmonary challenge.
Circulating levels of macrophage migration inhibitory factor are associated with mild pulmonary dysfunction after cardiopulmonary bypass.
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
Macrophage migration inhibitory factor and acute lung injury.
Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations.
Relationship between elevated soluble CD74 and severity of experimental and clinical ALI/ARDS.
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.
Tanshinone IIA attenuates seawater aspiration-induced lung injury by inhibiting macrophage migration inhibitory factor.
Adenocarcinoma
D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells.
Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa.
Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Adenocarcinoma of Lung
Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells.
Elevated expression of transforming growth factor betas and the tumor necrosis factor family in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
MIF family members cooperatively inhibit p53 expression and activity.
Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor.
Adenoma
Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Alopecia Areata
Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.
Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata.
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention.
Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata.
Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease.
Alphavirus Infections
Macrophage Migration Inhibitory Factor Receptor CD74 Mediates Alphavirus-Induced Arthritis and Myositis in Murine Models of Alphavirus Infection.
Alveolar Bone Loss
MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice.
Alzheimer Disease
Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
Corrigendum: Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.
Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
The role of macrophage migration inhibitory factor in Alzheimer's disease.
The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective?
Anemia
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System.
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.
Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.
Angina Pectoris
[The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors].
Angina, Stable
[The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors].
Angina, Unstable
[The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors].
Arteriosclerosis
Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer.
Arteriovenous Malformations
Macrophage migration inhibitory factor reduces apoptosis in cerebral arteriovenous malformations.
Arteritis
Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Arthralgia
Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia.
Arthritis
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.
A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis.
Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF).
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Lymphokines in rheumatoid synovitis.
Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis.
Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
Macrophage migration inhibitory factor and its genetic association with arthritis: a work in progress.
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator.
Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.
Macrophage Migration Inhibitory Factor Receptor CD74 Mediates Alphavirus-Induced Arthritis and Myositis in Murine Models of Alphavirus Infection.
Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice.
Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis.
Mapping of human B-cell epitopes of Sindbis virus.
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
Natural killer T cells ameliorate antibody-induced arthritis in macrophage migration inhibitory factor transgenic mice.
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis.
Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis.
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.
Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids.
The association between the functional PTPN22 1858 C/T and MIF -173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis.
Arthritis, Experimental
A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis.
Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF).
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.
Arthritis, Juvenile
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.
Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in turkish children with juvenile rheumatoid arthritis.
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
The association between the functional PTPN22 1858 C/T and MIF -173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis.
Arthritis, Psoriatic
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF? in psoriatic arthritis.
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.
Arthritis, Rheumatoid
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.
Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor.
Association of MIF-173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: A meta-analysis.
Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis.
Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.
Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Detection of sarcolectin-specific receptors like the cytokine macrophage migration inhibitory factor in rheumatoid nodules.
Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.
Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.
Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway.
Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.
Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis.
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.
Macrophage migration inhibitory factor in rheumatoid arthritis.
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.
Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.
Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.
Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis.
MIF and TNF? serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis.
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
MIF: a key player in cutaneous biology and wound healing.
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Plant-derived anti-inflammatory compounds affect MIF tautomerase activity.
Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.
Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction.
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.
Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course.
Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis.
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis.
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Th1/Th17 cytokine profile is induced by macrophage migration inhibitory factor in peripheral blood mononuclear cells from rheumatoid arthritis patients.
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.
The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae.
The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
Aspergillosis
A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
Asthma
Association of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma.
Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population.
Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation.
Crosstalk between MIF and Eotaxin in Allergic Eosinophil Activation Forms LTC4-Synthesizing Lipid Bodies.
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma.
Macrophage migration inhibitory factor (MIF) in bronchial asthma.
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation.
Macrophage migration inhibitory factor isolated from a parasite inhibited Th2 cytokine production in PBMCs of atopic asthma patients.
MIF signaling blocking alleviates airway inflammation and airway epithelial barrier disruption in a HDM-induced asthma model.
MIF: a key player in cutaneous biology and wound healing.
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Role for macrophage migration inhibitory factor in asthma.
Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice.
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats.
Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study.
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Ataxia Telangiectasia
Bioinformatics Based Therapeutic Effects of Sinomenium Acutum.
Atherosclerosis
A MIF-Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2.
Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.
Angiogenesis and vasculogenesis in rheumatoid arthritis.
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Association between the -794 (CATT)5-8??MIF gene polymorphism and susceptibility to acute coronary syndrome in a western Mexican population.
Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Chemokines and their receptors in Atherosclerosis.
Cytokines and atherosclerosis: a comprehensive review of studies in mice.
De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits.
De Novo expression of macrophage migration inhibitory factor in atherogenesis.
Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.
Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques.
Expression of Human Tissue Factor Pathway Inhibitor on Vascular Smooth Muscle Cells Inhibits Secretion of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerosis in ApoE-/- Mice.
Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis.
Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival.
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway.
Induction of MIF expression by oxidized LDL via activation of NF-kappaB in vascular smooth muscle cells.
Influence of functional polymorphism in MIF promoter on sudden cardiac death in Chinese populations.
Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.
Laminar Flow Attenuates Macrophage Migration Inhibitory Factor Expression in Endothelial Cells.
Lymphocyte migration into atherosclerotic plaque.
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques.
Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case-control study.
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
MIF: a key player in cutaneous biology and wound healing.
Modulation of circulating macrophage migration inhibitory factor in the elderly.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Platelet-derived MIF: A novel platelet chemokine with distinct recruitment properties.
Platelets are a previously unrecognised source of MIF.
Porphyromonas gingivalis ATCC 33277 promotes intercellular adhesion molecule-1 expression in endothelial cells and monocyte-endothelial cell adhesion through macrophage migration inhibitory factor.
Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis.
The expression of macrophage migration inhibitory factor and intercellular adhesion molecule-1 in rats with periodontitis and atherosclerosis.
The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.
The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.
[Macrophage migration inhibitory factor (MIF) gene -173 G>C polymorphism and its relationship to coronary artery disease and type 2 diabetes].
[Macrophage migration inhibitory factor and its role in atherosclerosis]
Atrial Fibrillation
Involvement of Src in L-type Ca2+ channel depression induced by macrophage migration inhibitory factor in atrial myocytes.
Involvement of Src tyrosine kinase and protein kinase C in the expression of macrophage migration inhibitory factor induced by H2O2 in HL-1 mouse cardiac muscle cells.
Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling.
Serum macrophage migration inhibitory factor is correlated with atrial fibrillation.
Autoimmune Diseases
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.
Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
Association study between macrophage migration inhibitory factor-173 polymorphism and acute myeloid leukemia in taiwan.
Biochemical and structural characterization of a novel cooperative binding mode by Pit-1 with CATT repeats in the macrophage migration inhibitory factor promoter.
Characterization of molecular determinants of the conformational stability of macrophage migration inhibitory factor: leucine 46 hydrophobic pocket.
Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.
Inhibition of Macrophage Migration Inhibitory Factor by a Chimera of Two Allosteric Binders.
Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.
Macrophage migration inhibitory factor (MIF) in chinese amphioxus as a molecular marker of immune evolution during the transition of invertebrate/vertebrate.
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF? in psoriatic arthritis.
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Macrophage migration inhibitory factor and its role in autoimmune diseases.
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Macrophage Migration Inhibitory Factor is not Associated with Sarcoidosis Susceptibility or Severity in Whites or Blacks.
Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.
Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
MIF and insulin: Lifetime companions from common genesis to common pathogenesis.
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
Nanosecond Dynamics Regulate the MIF-Induced Activity of CD74.
Prognostic Implication of MIF Gene Expression in Childhood Acute Lymphoblastic Leukemia.
Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes.
Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor.
Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.
Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Structure-activity relationships for binding of 4-substituted triazole-phenols to macrophage migration inhibitory factor (MIF).
The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
Bacteremia
Functional polymorphisms in the gene encoding macrophage migration inhibitory factor are associated with Gram-negative bacteremia in older adults.
Bacterial Infections
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages.
The Effect of Macrophage Migration Inhibitory Factor on Intestinal Permeability: FITC-Dextran Serum Measurement and Transmission Electron Microscopy.
Benign Paroxysmal Positional Vertigo
Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.
Biliary Atresia
Elevated Serum Macrophage Migration Inhibitory Factor Levels in Post-operative Biliary Atresia.
Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.
Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia.
Blister
UVB-induced inflammation gives increased d-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor.
Bone Resorption
Elevated Expression of Macrophage Migration Inhibitory Factor Promotes Inflammatory Bone Resorption Induced in a Mouse Model of Periradicular Periodontitis.
Borna Disease
Borna disease virus-induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Brain Edema
[Study on the expression and the role of macrophage migration inhibitory factor in the brain of neonatal rats with hypoxia-ischemia brain damage].
Brain Injuries
Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury.
Brain Injuries, Traumatic
Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury.
Brain Ischemia
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
The Association Between Serum Macrophage Migration Inhibitory Factor and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
Brain Neoplasms
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.
Breast Neoplasms
A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF).
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNF? in women with breast cancer.
Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.
Autophagy Inhibition Induces the Secretion of Macrophage Migration Inhibitory Factor (MIF) with Autocrine and Paracrine Effects on the Promotion of Malignancy in Breast Cancer.
Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology.
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.
Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201.
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Macrophage migration inhibitory factor involvement in breast cancer (Review).
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor.
Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism.
Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor.
[The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer]
Bronchiolitis
Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft.
Bronchopulmonary Dysplasia
A Polymorphism in the Macrophage Migration Inhibitory Factor Promoter is Associated With Bronchopulmonary Dysplasia.
Correction to: Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitigation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia.
Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitgation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia.
Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia.
Brucellosis
The IL4-VNTR P1 allele, IL4-VNTR P2P2 genotype and IL4-VNTR_IL6-174CG P2P1-GG genotype are susceptable with a increased risk in Brucelosis.
Caliciviridae Infections
Low serum levels of CCL5 are associated with longer duration of viral shedding in norovirus infection.
Carcinogenesis
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis.
Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.
Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer.
Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric Cancer.
Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis.
Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity.
Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis.
Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events.
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.
Macrophage migration inhibitory factor (MIF) interacts with Bim and inhibits Bim-mediated apoptosis.
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Macrophage migration inhibitory factor and oral cancer.
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Macrophage migration inhibitory factor induces autophagy via reactive oxygen species generation.
Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-?B activity.
Macrophage migration inhibitory factor involvement in breast cancer (Review).
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Macrophage migration inhibitory factor promotes colorectal cancer.
Macrophage migration inhibitory factor promotes intestinal tumorigenesis.
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Pleiotropic role of macrophage migration inhibitory factor in cancer.
Possible pathogenetic relationship between Fabry disease and renal cell carcinoma.
Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.
Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression.
Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor.
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice.
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis.
Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Carcinoma
Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Erratum: Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma.
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas.
HIF-?/MIF and NF-?B/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC.
In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma.
MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma.
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction].
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma.
Tumour Microenvironment in Skin Carcinogenesis.
[Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
[Expression of macrophage migration inhibition factor in pancreatic carcinoma tissue.]
[Expression of macrophage migration inhibitory factor, p53 and CD34 in ovarian carcinoma]
[Role of Bcl-2 and MIF proteins in senile patients with gingival cancer].
Carcinoma, Adenoid Cystic
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.
Carcinoma, Hepatocellular
Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models.
Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.
Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy.
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
Macrophage migration inhibitory factor plays a pivotal role in hepatocellular carcinoma and may be a noninvasive imaging target.
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma.
Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma.
Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
[Overexpression of miR-451a inhibits cell proliferation by targeted macrophage migration inhibitory factor in HepG2 cells].
[Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis]
Carcinoma, Non-Small-Cell Lung
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
The expression of macrophage migration inhibitory factor in the non-small cell lung cancer.
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
[Expression and significance of MIF and CD147 in non-small cell lung cancer]
Carcinoma, Renal Cell
Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma.
Carcinoma, Squamous Cell
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma.
HIF-?/MIF and NF-?B/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC.
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma.
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Tumour Microenvironment in Skin Carcinogenesis.
[Corrigendum] Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Cardiomegaly
Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.
Cardiomyopathies
Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with chagas disease.
Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease.
Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy.
Mannose Binding Lectin and Macrophage Migration Inhibitory Factor Gene Polymorphisms in Turkish Children with Cardiomyopathy: No Association with MBL2 Codon 54 A/B Genotype, but an Association between MIF -173 CC Genotype.
Cardiovascular Diseases
Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes.
Decreased Plasma Levels of Clusterin in Patients With Psoriasis.
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome.
Elevated plasma macrophage migration inhibitor factor as a risk factor for the development of post-stroke depression in ischemic stroke.
Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: Association with echocardiographic indices and disease severity.
Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.
LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Macrophage migration inhibitory factor in cardiovascular disease.
Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells.
Macrophage migration inhibitory factor knockout attenuates endotoxin induced cardiac dysfunction in mice.
Macrophage migration inhibitory factor serves a pivotal role in the regulation of radiation-induced cardiac senescencethrough rebalancing the microRNA-34a/sirtuin 1 signaling pathway.
Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?
MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.
Obesity, macrophage migration inhibitory factor, and weight loss.
Studying the Pro-Migratory Effects of MIF.
Cataract
Lens epithelial cell mRNA. III. Elevated expression of macrophage migration inhibitory factor mRNA in galactose cataracts.
Celiac Disease
Involvement of macrophage migration inhibitory factor gene in celiac disease susceptibility.
Central Nervous System Infections
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.
Cerebral Hemorrhage
Macrophage migration inhibitory factor levels in serum from patients with acute intracerebral hemorrhage: Potential contribution to prognosis.
Cerebral Infarction
Baicalein attenuates caspase-independent cells death via inhibiting PARP-1 activation and AIF nuclear translocation in cerebral ischemia/reperfusion rats.
Chagas Disease
Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease.
Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with chagas disease.
Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Chemical and Drug Induced Liver Injury
Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness.
Cholesteatoma
Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Chondrosarcoma
Macrophage migration inhibitory factor increases cell motility and up-regulates ?v?3 integrin in human chondrosarcoma cells.
Chorioamnionitis
Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
Choriocarcinoma
Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells.
Chronic Periodontitis
Association of macrophage migration inhibitory factor gene polymorphisms with chronic periodontitis in a South Eastern Iranian population.
Macrophage Migration Inhibitory Factor Levels in Gingival Crevicular Fluid, Saliva, and Serum of Chronic Periodontitis Patients.
Clostridium Infections
Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.
Coinfection
KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
Colitis
A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through Toll-like receptor 2.
Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing.
Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.
DNA vaccination targeting macrophage migration inhibitory factor prevents murine experimental colitis.
Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis.
Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice.
Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice.
Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.
Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.
Wuchereria bancrofti macrophage migration inhibitory factor-2 (rWbaMIF-2) ameliorates experimental colitis.
[The role of macrophage migration inhibitory factor (MIF) for dextran sulfate sodium-induced colitis in mice]
Colitis, Ulcerative
Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan.
Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
Baicalin Down-regulates the Expression of Macrophage Migration Inhibitory Factor (MIF) Effectively for Rats with Ulcerative Colitis.
Changes in the plasma level of macrophage migration inhibitory factor in ulcerative colitis patients treated with selective granulocyte and monocyte apheresis.
Emerging views of mitophagy in immunity and autoimmune diseases.
Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis.
Macrophage migration inhibitory factor and activator protein-1 in ulcerative colitis.
Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis.
Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance.
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.
Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.
Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity.
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
[Interaction of MIF gene -173G/C polymorphism and GPX1 gene 594C/T polymorphism with high-fat diet in ulcerative colitis].
Colitis-Associated Neoplasms
Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
Colonic Neoplasms
ALA-mediated photodynamic effect on apoptosis induction, and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1), by colon cancer cells in normoxia and in hypoxia-like conditions in vitro.
Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.
Development and application of a method for identification of isothiocyanate-targeted molecules in colon cancer cells.
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.
Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer.
The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.
Colorectal Neoplasms
Macrophage migration inhibitory factor in cancer.
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells.
Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
Macrophage migration inhibitory factor promotes colorectal cancer.
Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells.
Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.
[MiR-451 regulates proliferation and migration of colorectal cells by targeting MIF].
Communicable Diseases
Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.
Identification and Structure-Activity Relationships of Dietary Flavonoids as Human Macrophage Migration Inhibitory Factor (MIF) Inhibitors.
Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.
Conjunctivitis, Allergic
Correction: Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.
Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice.
Contracture
Macrophage migration inhibitory factor activates the inflammatory response in joint capsule fibroblasts following post-traumatic joint contracture.
Corneal Injuries
Expression of macrophage migration inhibitory factor in corneal wound healing in rats.
Corneal Neovascularization
Role of macrophage migration inhibitory factor in corneal neovascularization.
[Mechanisms and regulation of corneal neovascularization]
Coronary Artery Disease
Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population.
Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery disease.
Gremlin-1 C-Terminus Regulates Function of Macrophage Migration Inhibitory Factor (MIF).
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease.
Increased expression of macrophage migration inhibitory factor in aorta of patients with coronary atherosclerosis.
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population: A Case-Control Study.
Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.
Coronary Disease
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease.
[Association between plasma macrophage migration inhibitory factor concentration and coronary artery lesion severity.]
[Association of the polymorphism of macrophage migration inhibitory factor gene with coronary heart disease in Chinese population]
Coronary Occlusion
Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries.
COVID-19
Does Macrophage Migration Inhibitory Factor predict the prognosis of COVID-19 disease?
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study.
Crohn Disease
A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses.
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
Emerging views of mitophagy in immunity and autoimmune diseases.
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Cystic Fibrosis
Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa-induced inflammation and biofilm formation.
Calcium-binding proteins of the EF-type.
Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients.
Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation potentially contributing to cystic fibrosis pathogenesis.
Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
Cystitis
Alterations of Macrophage Migration Inhibitory Factor Expression in the Nervous System of the Rat Cystitis Model.
Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association.
Hydrochloric acid induced changes in macrophage migration inhibitory factor in the bladder, peripheral and central nervous system of the rat.
Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation.
Cysts
Macrophage migration inhibitory factor is regulated by HIF-1? and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Polycystic kidney disease: Macrophage migration inhibitory factor regulates cyst growth in ADPKD.
Dementia
Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Dengue
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
CORRELATION OF SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR WITH DISEASE SEVERITY AND CLINICAL OUTCOME IN DENGUE PATIENTS.
Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways.
Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy.
Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability.
Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability.
Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy.
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
Roles of Macrophage Migration Inhibitory Factor in Dengue Pathogenesis: From Pathogenic Factor to Therapeutic Target.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Dermatitis
Berberine induces anti-atopic dermatitis effects through the downregulation of cutaneous EIF3F and MALT1 in NC/Nga mice with atopy-like dermatitis.
Correction: Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.
Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis.
Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice.
Dermatitis, Atopic
Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea.
DNA vaccination against macrophage migration inhibitory factor improves atopic dermatitis in murine models.
Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis.
Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.
Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis.
Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.
Macrophage migration inhibitory factor promoter 173G/C polymorphism is associated with atopic dermatitis risk.
Measurement of serum macrophage migration inhibitory factor (MIF) and correlation with severity and pruritus scores in client owned dogs with atopic dermatitis.
Dermatitis, Contact
Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
Macrophage migration inhibitory factor in zinc-allergic systemic contact dermatitis.
Diabetes Mellitus
Altered Macrophage and Dendritic Cell Response in
Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Fenofibrate attenuates fatty acid-induced islet ?-cell dysfunction and apoptosis via inhibiting the NF-?B/MIF dependent inflammatory pathway.
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia.
Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus.
Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus.
Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function.
Diabetes Mellitus, Type 1
Altered Macrophage and Dendritic Cell Response in
Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes.
Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.
Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Macrophage migration inhibitory factor (MIF) enhances palmitic acid- and glucose-induced murine beta cell dysfunction and destruction in vitro.
Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia.
Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus.
Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus.
Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function.
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes.
Diabetes, Gestational
Association between macrophage migration inhibitory factor rs1007888 and GDM.
Association of Macrophage Migration Inhibitory Factor Polymorphisms with Gestational Diabetes Mellitus in Han Chinese Women.
Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome.
[Association between single nucleotide polymorphism of macrophage migration inhibitory factor-rs1007888 and the pathogenesis of gestational diabetes mellitus].
[Expression of macrophage migration inhibitory factor gene in placenta tissue and its correlation with gestational diabetes mellitus].
Diabetic Cardiomyopathies
Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor.
Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.
Diabetic Nephropathies
Inhibition of Macrophage Migration Inhibitory Factor Reduces Diabetic Nephropathy in Type II Diabetes Mice.
Macrophage migration inhibitory factor antagonist (p425) ameliorates kidney histopathological and functional changes in diabetic rats.
The MIF receptor CD74 in diabetic podocyte injury.
TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells.
Diabetic Neuropathies
Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy.
Diabetic Retinopathy
Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy.
The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.
Diffuse Axonal Injury
Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation through a Toll-like Receptor-Related Pathway after Diffuse Axonal Injury in Rats.
Disseminated Intravascular Coagulation
High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
Distemper
Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.
Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression.
Down Syndrome
Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: Relation to hemodynamic parameters and the presence of Down syndrome.
Dysentery, Amebic
Entamoeba histolytica-Encoded Homolog of Macrophage Migration Inhibitory Factor Contributes to Mucosal Inflammation during Amebic Colitis.
Encephalitis
Association between high expression macrophage migration inhibitory factor (MIF) alleles and West Nile virus encephalitis.
Borna disease virus-induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration.
Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Encephalitis, Japanese
Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain.
Encephalitis, Tick-Borne
The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis.
Encephalomyelitis
Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
Encephalomyelitis, Autoimmune, Experimental
Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
Endometrial Neoplasms
Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: A pilot study.
Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma.
Expression of MIF and c-erbB-2 in endometrial cancer.
Endometriosis
A novel gene-wide haplotype at the macrophage migration inhibitory factor (MIF) locus is associated with endometrioma.
Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis.
Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis.
Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis.
Expression of macrophage migration inhibitory factor in human endometriosis: relation to disease stage, menstrual cycle and infertility.
Expression of MMIF, HIF-1? and VEGF in Serum and Endometrial Tissues of Patients with Endometriosis.
Hepatocyte nuclear factor (HNF)-1? and its physiological importance in endometriosis.
Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis.
Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo.
Macrophage migration inhibitory factor as a potential biomarker of endometriosis.
Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain.
Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis.
Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development.
Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis.
Panel of markers can accurately predict endometriosis in a subset of patients.
Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment.
Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis.
Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB.
The Relationship between Functional Promoter Variants of Macrophage Migration Inhibitory Factor and Endometriosis.
Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.
Endotoxemia
Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia.
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations.
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Enterocolitis
Increased levels of macrophage migration inhibitory factor in sera of patients with Escherichia coli O157:H7-induced enterocolitis.
Enterocolitis, Necrotizing
The macrophage migration inhibitory factor -173G/C polymorphism is not significantly associated with necrotizing enterocolitis in preterm infants.
Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis.
Eosinophilia
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Eosinophilic Esophagitis
Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis.
Epilepsy
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Epstein-Barr Virus Infections
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Erythema Nodosum
Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome.
Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.
Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
Esophageal Squamous Cell Carcinoma
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Esophagitis, Peptic
Leptin Aggravates Reflux Esophagitis by Increasing Tissue Levels of Macrophage Migration Inhibitory Factor in Rats.
Eye Infections
Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection.
Familial Mediterranean Fever
Increased levels of macrophage migration inhibitory factor in patients with familial mediterranean Fever.
Familial Primary Pulmonary Hypertension
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Fatty Liver
Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease.
Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis.
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Febrile Neutropenia
Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, d-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Fetal Growth Retardation
Macrophage migration inhibitory factor in fetoplacental tissues from preeclamptic pregnancies with or without fetal growth restriction.
Foot Ulcer
Immune mediators in patients with acute diabetic foot syndrome.
Gallbladder Neoplasms
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Gastritis
Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.
Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori.
Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and chronic gastritis.
Gastritis, Atrophic
Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.
Gastrointestinal Neoplasms
Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Giant Cell Arteritis
Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Gingivitis
Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Salivary and Serum Markers Related to Innate Immunity in Generalized Aggressive Periodontitis.
Glioblastoma
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).
Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression.
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
Macrophage migration inhibitory factor enhances autophagy by regulating ROCK1 activity and contributes to the escape of dendritic cell surveillance in glioblastoma.
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells.
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma.
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Glioma
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas.
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
miR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
The dexamethasone-induced inhibition of proliferation, migration and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors.
[Promoting migration and apoptosis of glioma cells by macrophage migration inhibitory factor].
Glomerulonephritis
A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.
Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
Expression of macrophage migration inhibitory factor in human glomerulonephritis.
Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy.
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Macrophage migration inhibitory factor regulates integrin-?1 and cyclin D1 expression via ERK pathway in podocytes.
Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis.
Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.
Serum levels of macrophage migration inhibitory factor in various types of glomerulonephritis.
TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney.
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Glomerulonephritis, IGA
Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy.
Macrophage migration inhibitory factor in IgA nephropathy.
Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.
Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.
Glomerulonephritis, Membranous
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy.
Glucose Intolerance
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice.
Gout
Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1? production in a murine model of acute gout.
Reciprocal interaction between macrophage migration inhibitory factor and interleukin-8 in gout.
Graft vs Host Disease
Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Granuloma
Increased density of macrophage migration inhibitory factor (MIF) in tuberculosis granuloma.
Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.
Granulomatosis with Polyangiitis
Role of macrophage migration inhibitory factor in granulomatosis with polyangiitis.
Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis.
Graves Disease
Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset graves disease in a taiwanese chinese population.
Guillain-Barre Syndrome
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Macrophage migration inhibitory factor is necessary for the Lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients.
Hamartoma
The -173 G/C polymorphism of the promoter region macrophage migration inhibitory factor gene is not associated with incidence of pulmonary hamartoma.
Head and Neck Neoplasms
Macrophage migration inhibitory factor modulates proliferation, cell cycle, and apoptotic activity in head and neck cancer cell lines.
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Hearing Loss
Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation.
Role of macrophage migration inhibitory factor in age-related hearing loss.
Hearing Loss, Noise-Induced
Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation.
Hearing Loss, Sensorineural
Association between Macrophage Migration Inhibitory Factor Gene Variation and Response to Glucocorticoid Treatment in Sudden Sensorineural Hearing Loss.
The polymorphisms of the MBL2 and MIF genes associated with Pediatric Cochlear Implant Patients.
Heart Arrest
Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest.
Heart Diseases
Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury.
Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis.
Heart Failure
Cardiomyocyte d-dopachrome tautomerase protects against heart failure.
Circulating macrophage migration inhibitory factor (MIF) in patients with heart failure.
Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: Association with echocardiographic indices and disease severity.
Myocardial Expression of Macrophage Migration Inhibitory Factor in Patients with Heart Failure.
Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF).
Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsy.
T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.
[Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure]
Henipavirus Infections
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatitis
Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Hepatitis B
Relationship among MIF, MCP-1, viral loads, and HBs Ag levels in chronic hepatitis B patients.
Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury.
Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Hepatitis B, Chronic
Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort.
Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection.
Hepatitis C
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatitis, Autoimmune
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
Correction: Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis.
Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis.
The role of macrophage migration inhibitory factor (MIF) in autoimmune liver disease.
Herpes Zoster
Cytokine expression in the rat adrenal cortex.
Epididymosomes are involved in the acquisition of new sperm proteins during epididymal transit.
HIV Infections
Low expression Macrophage Migration Inhibitory Factor (MIF) alleles and tuberculosis in HIV infected South Africans.
Hyperalgesia
Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalgesia in rats.
Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity.
Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.
Vitamin E is a MIF Inhibitor.
Hyperglycemia
Advances in prognostic factors in acute pancreatitis: a mini-review.
Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
Insulin in sepsis and septic shock.
The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice.
Hyperpigmentation
The regulation of protein kinase casein kinase II by apigenin is involved in the inhibition of ultraviolet B-induced macrophage migration inhibitory factor-mediated hyperpigmentation.
Hypersensitivity
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.
Antigen induced inhibition of autoimmune response to rat male accessory glands: role of thymocytes on the efferent phase of the suppression.
Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection.
Cardiac allograft rejection in the absence of macrophage migration inhibitory factor.
Cell-mediated immunity in ferrets. Delayed dermal hypersensitivity, lymphocyte transformation, and macrophage migration inhibitory factor production.
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
Dextran sulphate: an adjuvant for cell-mediated immune responses.
Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition.
Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.
Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.
Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Macrophage migration inhibitory factor mediates peripheral nerve injury-induced hypersensitivity by curbing dopaminergic descending inhibition.
Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity.
Structural nature and functions of transfer factors.
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Hypersensitivity, Delayed
Immune protective mechanisms during pregnancy. I. Cell-mediated immunity against Listeria monocytogenes in pregnant mice.
Macrophage migration inhibitory factor (MIF) in guinea pigs and humans with delayed hypersensitivity.
Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice.
Studies on the biosynthesis of macrophage migration inhibitory factor in delayed hypersensitivity. I. Effects of inhibitors of nucleic acid and protein synthesis on the production of macrophage migration inhibitory factor.
Hypertension
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension.
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study.
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor ? in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
Hypertension, Pulmonary
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells.
Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: Relation to hemodynamic parameters and the presence of Down syndrome.
Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.
Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension.
Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac Shunts.
Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension.
The effects of genetic deletion of Macrophage migration inhibitory factor on the chronically hypoxic pulmonary circulation.
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Hypertension, Renovascular
Increased Expression of Macrophage Migration Inhibitory Factor in the Nucleus of the Solitary Tract Attenuates Renovascular Hypertension in Rats.
Idiopathic Pulmonary Fibrosis
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients.
Immune System Diseases
Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population.
Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays.
Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and chronic gastritis.
Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases.
Macrophage Migration Inhibitory Factor Mediates Neuroprotective Effects by Regulating Inflammation, Apoptosis and Autophagy in Parkinson's Disease.
Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders.
Infarction, Middle Cerebral Artery
Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke.
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Infections
A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection.
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
Alpha-thrombin stimulates expression of macrophage migration inhibitory factor in skin fibroblasts.
Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
Characterization of Chinese giant salamander iridovirus tissue tropism and inflammatory response after infection.
Characterization of MIF family proteins: MIF and DDT from rock bream, Oplegnathus fasciatus.
Chimeric DNA vaccines encoding Eimeria acervulina macrophage migration inhibitory factor (E.MIF) induce partial protection against experimental Eimeria infection.
Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes.
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
CORRELATION OF SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR WITH DISEASE SEVERITY AND CLINICAL OUTCOME IN DENGUE PATIENTS.
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Differential susceptibility of human trophoblastic (BeWo) and uterine cervical (HeLa) cells to Neospora caninum infection.
Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression.
Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors.
Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.
Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction.
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Gastric cancer susceptibility in gastric cancer relatives: Attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori.
Gastric epithelial expression of macrophage migration inhibitory factor is not altered by Helicobacter pylori infection in humans.
Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection.
Human cytomegalovirus-mediated induction of MIF in fibroblasts.
Immunohistochemical detection of macrophage migration inhibitory factor in fetal and adult bovine epididymis: release by the apocrine secretion mode?
Increased density of macrophage migration inhibitory factor (MIF) in tuberculosis granuloma.
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection.
Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Interaction Between Macrophage Migration Inhibitory Factor and CD74 in Human Immunodeficiency Virus Type I Infected Primary Monocyte-Derived Macrophages Triggers the Production of Proinflammatory Mediators and Enhances Infection of Unactivated CD4+ T Cells.
Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.
Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor.
Macrophage migration inhibitory factor and placental malaria infection in an area characterized by unstable malaria transmission in central Sudan.
Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes.
Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection.
Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.
Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection.
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Macrophage Migration Inhibitory Factor is Increased in the Urine of Patients With Urinary Tract Infection: Macrophage Migration Inhibitory Factor-Protein Complexes in Human Urine.
Macrophage migration inhibitory factor levels correlate with an infection in trauma patients.
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
Macrophage Migration Inhibitory Factor Triggers Inflammatory Responses During Very Virulent Infectious Bursal Disease Virus Infection.
Macrophage migration inhibitory factor, infection, the brain, and corticosteroids.
MIF participates in Toxoplasma gondii-induced pathology following oral infection.
MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.
Migration inhibitory factor expression in experimentally induced endotoxemia.
NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection.
Natural killer cell activity in experimental paracoccidioidomycosis of the Syrian hamster.
Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.
Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria.
Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
The association between MIF-173 G>C polymorphism and prostate cancer in southern Chinese.
The effect of Helicobacter pylori infection on expression of macrophage migration inhibitory factor by T cells and macrophages in gastric mucosa.
The effect of snakehead fish extract supplementation to first-line eradication regimen on macrophage migration inhibitory factor (MIF) expression in rats induced by Helicobacter pylori infection.
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle.
The relevance of the migration inhibitory factor (MIF) for peripheral tissue response in murine sublethal systemic Aspergillus fumigatus infection.
The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice.
Urinary macrophage migration inhibitory factor in children with urinary tract infection.
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis.
WITHDRAWN: Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Infertility
Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis.
Direct effect of macrophage migration inhibitory factor on sperm function: possible involvement in endometriosis-associated infertility.
Expression of macrophage migration inhibitory factor in human endometriosis: relation to disease stage, menstrual cycle and infertility.
Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain.
Infertility, Female
Macrophage migration inhibitory factor in female sterility.
Inflammatory Bowel Diseases
A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population.
Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease.
Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.
CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing.
Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.
Emerging views of mitophagy in immunity and autoimmune diseases.
Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.
Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk.
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
MIF: a key player in cutaneous biology and wound healing.
Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease.
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease.
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis.
The macrophage migration inhibitory factor -173G/C polymorphism is not significantly associated with necrotizing enterocolitis in preterm infants.
Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.
Influenza, Human
Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.
Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection.
Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia.
Insulin Resistance
A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome.
Disturbances of systemic and hippocampal insulin sensitivity in macrophage migration inhibitory factor (MIF) knockout male mice lead to behavioral changes associated with decreased PSA-NCAM levels.
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.
Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5?-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy.
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.
Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance.
Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes.
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
Intervertebral Disc Degeneration
Migration Inhibitory Factor Enhances Inflammation via CD74 in Cartilage End Plates with Modic Type 1 Changes on MRI.
Intracranial Arteriovenous Malformations
Macrophage migration inhibitory factor reduces apoptosis in cerebral arteriovenous malformations.
Iridocyclitis
Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis.
Ischemic Stroke
Early treadmill exercise increases macrophage migration inhibitory factor expression after cerebral ischemia/reperfusion.
Macrophage Migration Inhibitory Factor Alters Functional Properties of CA1 Hippocampal Neurons in Mouse Brain Slices.
Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.
Serum level of macrophage migration inhibitory factor predicts severity and prognosis in patients with ischemic stroke.
Serum macrophage migration inhibitory factor levels are associated with infarct volumes and long-term outcomes in patients with acute ischemic stroke.
Joint Diseases
Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis.
Keloid
Comparative proteomic analysis between normal skin and keloid scar.
[High expression of macrophage migration inhibitory factor and its role in cellular proliferation and extracellular matrix production in keloid fibroblasts]
[Interaction between macrophage migration inhibitory factor and lysophosphatidic acid in formation of keloid tissue]]
Keratitis
CD74 deficiency ameliorates Pseudomonas aeruginosa-induced ocular infection.
Expression of macrophage migration inhibitory factor during Pseudomonas keratitis.
Expression of macrophage migration inhibitory factor in Aspergillus fumigatus keratitis.
Human Corneal MicroRNA Expression Profile in Fungal Keratitis.
Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis.
Kidney Diseases
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells.
Macrophage migration inhibitory factor as a potential predictor for requirement of renal replacement therapy after orthotopic liver transplantation.
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
MIF, CD74 and other partners in kidney disease: Tales of a promiscuous couple.
Role of macrophage migration inhibition factor in kidney disease.
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Kidney Failure, Chronic
Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis.
Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
Leishmaniasis, Visceral
Variations in macrophage migration inhibitory factor gene are not associated with visceral leishmaniasis in India.
Leprosy
Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
Leukemia
Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma.
Folliculo-stellate cells - potential mediators of the inflammaging-induced hyperactivity of the hypothalamic-pituitary-adrenal axis in healthy elderly individuals.
Identification of macrophage migration inhibitory factor in human leukemia HL-60 cells and its induction by lipopolysaccharide.
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Leukemia, Lymphocytic, Chronic, B-Cell
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Liver Cirrhosis
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide.
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.
Liver Cirrhosis, Biliary
Emerging views of mitophagy in immunity and autoimmune diseases.
The role of macrophage migration inhibitory factor (MIF) in autoimmune liver disease.
Liver Diseases
Hypothesis: Targeted Ikk? deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes.
Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease.
Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Novel Role of Macrophage Migration Inhibitory Factor in Upstream Control of the Unfolded Protein Response After Ethanol Feeding in Mice.
The role of macrophage migration inhibitory factor (MIF) in autoimmune liver disease.
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Liver Diseases, Alcoholic
Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues.
Macrophage Migration Inhibitory Factor: New Insights into the Pathogenesis of Alcoholic Liver Disease.
Mechanisms of alcoholic liver disease: cytokines.
Liver Failure
Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice.
Liver Neoplasms
Efficacy analysis of combined detection of 5 Serological Tumor markers including MIF and PIVKA-II for early diagnosis of Primary Hepatic Cancer.
Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma.
In Vivo Imaging of the Macrophage Migration Inhibitory Factor in Liver Cancer with an Activity-Based Probe.
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.
Lung Diseases
Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.
Role of macrophage migration inhibitory factor in age-related lung disease.
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Lung Injury
Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage.
Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury.
ESTROGEN AUGMENTS THE PROTECTION OF HYPERTONIC SALINE TREATMENT FROM MESENTERIC ISCHEMIA REPERFUSION INJURY.
Macrophage migration inhibitory factor antagonist (S,R)3?(4?hydroxyphenyl)?4,5?dihydro?5?isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy.
Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.
Role for macrophage migration inhibitory factor in acute respiratory distress syndrome.
Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice.
Tanshinone IIA attenuates seawater aspiration-induced lung injury by inhibiting macrophage migration inhibitory factor.
Lung Neoplasms
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Correction: Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human h460 lung cancer cells by caspase-dependent apoptosis.
Dissociation of MIF-rpS3 complex and sequential NF-?B activation is involved in IR-induced metastatic conversion of NSCLC.
Effect and molecular mechanism of mir-146a on proliferation of lung cancer cells by targeting and regulating MIF gene.
Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.
Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF??B/HIF?1? pathway in lung cancer.
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells.
Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
RNF138-mediated ubiquitination of rpS3 is required for resistance of glioblastoma cells to radiation-induced apoptosis.
The expression of macrophage migration inhibitory factor in the non-small cell lung cancer.
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
[Expression and significance of MIF and CD147 in non-small cell lung cancer]
Lupus Erythematosus, Discoid
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
Lupus Erythematosus, Systemic
Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus.
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis.
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.
Emerging views of mitophagy in immunity and autoimmune diseases.
Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus.
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE).
Levels of the macrophage migration inhibitory factor and polymorphisms in systemic lupus erythematosus: a meta-analysis.
Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Macrophage migration inhibitory factor in systemic lupus erythematosus.
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
Macrophage migration inhibitory factor: Association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-? in systemic lupus erythematosus.
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus.
[The expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosus]
[The relationship between mRNA level of glucocorticoid receptor ?, heat shock protein 90, protein level of macrophage migration inhibitory factor and glucocorticoid resistance in systemic lupus erythematosus].
Lupus Nephritis
Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.
miR-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (MIF)-Induced Expression of COL1A1.
MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus.
Lymphatic Metastasis
Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically.
Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis.
Lymphoma
An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.
Lymphoma, B-Cell
A study on the biological function of heat shock factor 1 proteins in breast cancer.
Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury.
Malaria
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
Detection of Plasmodium falciparum derived macrophage migration inhibitory factor homologue in the sera of malaria patients.
Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria.
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria.
Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood.
Macrophage migration inhibitory factor and placental malaria infection in an area characterized by unstable malaria transmission in central Sudan.
Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection.
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.
Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria.
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
Malaria, Cerebral
Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India.
Malaria, Falciparum
A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
Marek Disease
Potential Role of Macrophage Migration Inhibitory Factor in the Pathogenesis of Marek's Disease.
Maternal Death
Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis.
Melanoma
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-?.
Emerging views of mitophagy in immunity and autoimmune diseases.
High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Macrophage migration inhibitory factor in cancer.
Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.
Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes.
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival.
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model.
Tumour Microenvironment in Skin Carcinogenesis.
[BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]
Melioidosis
Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.
Meningioma
Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.
Meningitis
Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae.
Meningitis, Bacterial
Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.
Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis.
Meningitis, Pneumococcal
Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.
Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis.
Macrophage migration inhibitory factor, infection, the brain, and corticosteroids.
Patterns of protein expression in infectious meningitis: a cerebrospinal fluid protein array analysis.
Meningococcal Infections
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Metabolic Diseases
Macrophage migration inhibitory factor in the regulation of myoblast proliferation and differentiation.
Metabolic Syndrome
Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome.
Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome.
Macrophage migration inhibitory factor inhibition is deleterious for high-fat diet-induced cardiac dysfunction.
Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Microscopic Polyangiitis
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.
Mouth Neoplasms
Macrophage migration inhibitory factor and oral cancer.
Mucocele
Role of macrophage migration inhibitory factor in paranasal sinus mucocele.
Mucocutaneous Lymph Node Syndrome
High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease.
Multiple Myeloma
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.
Multiple Sclerosis
Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients.
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.
CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
Is multiple sclerosis a proresolution deficiency disorder?
Macrophage migration inhibitory factor as a target molecule in multiple sclerosis.
Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease.
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.
MIF and D-DT are potential disease severity modifiers in male MS subjects.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.
Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis.
Muscular Dystrophy, Duchenne
Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy.
Myocardial Infarction
Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction.
Circulating MIF Levels Predict Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction After Percutaneous Coronary Intervention.
Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes.
Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.
Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction.
Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction.
Influence of functional polymorphism in MIF promoter on sudden cardiac death in Chinese populations.
Lack of Macrophage Migration Inhibitory Factor Reduces Susceptibility to Ventricular Arrhythmias During the Acute Phase of Myocardial Infarction.
Macrophage migration inhibitory factor (MIF) elevation in acute myocardial infarction is arteriogenic.
Macrophage Migration Inhibitory Factor (MIF) Expression Increases during Myocardial Infarction and Supports Pro-Inflammatory Signaling in Cardiac Fibroblasts.
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p.
Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction.
The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.
Myocardial Ischemia
Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia.
Myocarditis
Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis.
Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
Myositis
Co-Localization of Macrophage Inhibitory Factor and Nix in Skeletal Muscle of the Aged Male Interleukin 10 Null Mouse.
Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.
Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies.
Macrophage Migration Inhibitory Factor Receptor CD74 Mediates Alphavirus-Induced Arthritis and Myositis in Murine Models of Alphavirus Infection.
Nasal Polyps
The effects of systemic steroid therapy on macrophage migration inhibitory factor concentrations in patients with nasal polyps.
The role of serum macrophage migration inhibitory factor in preoperative prediction of chronic rhinosinusitis with nasal polyps endotypes.
Nasopharyngeal Carcinoma
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma.
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
[Effect of macrophage migration inhibitory factor (MIF) on expression of MMP-2,MMP-9,and IL-8 in nasopharyngeal carcinoma cell strains]
[Increased cell migration of nasopharyngeal carcinoma cell lines in vitro by macrophage migration inhibitory factor]
Nematode Infections
A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection.
Neoplasm Metastasis
Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically.
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Dissociation of MIF-rpS3 complex and sequential NF-?B activation is involved in IR-induced metastatic conversion of NSCLC.
Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts.
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Macrophage migration inhibitory factor promotes colorectal cancer.
Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF??B/HIF?1? pathway in lung cancer.
Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
[Increased cell migration of nasopharyngeal carcinoma cell lines in vitro by macrophage migration inhibitory factor]
Neoplasms
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
7-Hydroxycoumarins are Affinity-based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor.
A Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent Inhibitors.
A Long-Term High-Fat/High-Sucrose Diet Promotes Kidney Lipid Deposition and Causes Apoptosis and Glomerular Hypertrophy in Bama Minipigs.
A multi-targeted approach to suppress tumor-promoting inflammation.
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.
A STUDY OF THE CLINICAL AND BIOCHEMICAL PROFILE OF PERITONEAL DIALYSIS FLUID LOW IN GLUCOSE DEGRADATION PRODUCTS.
Accelerated degradation of collagen membranes in type 1 diabetic rats is associated with increased expression and production of several inflammatory molecules.
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.
Adipokine gene transcription level in adipose tissue of runt piglets.
Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic.
An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis.
Analysis of chicken TLR4, CD28, MIF, MD-2, and LITAF genes in a Salmonella enteritidis resource population.
Antitumor immunity in strain 2 guinea pigs immunized with potassium chloride extracts of L2C tumor cells.
APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease.
Apoptotic neutrophils release macrophage migration inhibitory factor upon stimulation with tumor necrosis factor-alpha.
Assessing chronic pelvic pain syndrome patients: Blood plasma factors and cortisol saliva.
Assessment of the ovine acute phase response and hepatic gene expression in response to Escherichia coli endotoxin.
Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysis.
Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.
Association of genetic polymorphisms in MIF with breast cancer risk in Chinese women.
Association of Oxytocin with Glucose Intolerance and Inflammation Biomarkers in Metabolic Syndrome Patients with and without Prediabetes.
Association of Peripheral Blood Levels of Cytokines With Autism Spectrum Disorder: A Meta-Analysis.
Association of twelve immune-related genes with performance of three broiler lines in two different hygiene environments.
Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells.
Auraptene attenuates gastritis via reduction of Helicobacter pylori colonization and pro-inflammatory mediator production in C57BL/6 mice.
Autophagy Inhibition Induces the Secretion of Macrophage Migration Inhibitory Factor (MIF) with Autocrine and Paracrine Effects on the Promotion of Malignancy in Breast Cancer.
Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases.
Biochemical and structural characterization of a novel cooperative binding mode by Pit-1 with CATT repeats in the macrophage migration inhibitory factor promoter.
Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Cardiovascular protective role for activated protein C during endotoxemia in rats.
CD4+ T cells play a dominant role in protection against New World leishmaniasis induced by vaccination with the P-4 amastigote antigen.
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-?.
Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Cellular characterization of the peritumoral edema zone in malignant brain tumors.
Cerebral palsy is characterized by protein mediators in cord serum.
Change of macrophage migration inhibitory factor: possible indicator for postoperative prognosis.
Changes in systemic and subcutaneous adipose tissue inflammation and oxidative stress in response to exercise training in obese black African women.
Characterization of Chinese giant salamander iridovirus tissue tropism and inflammatory response after infection.
Characterization of synthetic lung surfactant activity against proinflammatory cytokines in human monocytes.
Chronic psychological stress induces vascular inflammation in rabbits.
Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile.
Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric Cancer.
Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, d-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Comparative proteomic analysis between normal skin and keloid scar.
Compartmentalization of the inflammatory response in sepsis and SIRS.
Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.
Construction of Expanded Prefabricated Adipose Tissue Using an External Volume Expansion Device.
Contribution of aorta glycosaminoglycans and PCSK9 to hyperlipidemia in experimental rabbits: the role of 10-dehdrogingerdione as effective modulator.
Contribution of Macrophage Migration Inhibitory Factor -173G/C Gene Polymorphism to the Risk of Cancer in Chinese Population.
Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment.
Curcumin protects against sepsis-induced acute lung injury in rats.
Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea.
Cytokine expression in the rat adrenal cortex.
Cytokine patterns in patients with cancer: a systematic review.
Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.
Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity.
D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins.
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor.
Developmental endothelial locus-1 inhibits MIF production through suppression of NF-?B in macrophages.
Differential patterns of 27 cord blood immune biomarkers across gestational age.
Differential protein expression in primary breast cancer and matched axillary node metastasis.
Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface.
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays.
Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1.
Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.
Effect of asymmetric dimethylarginine on MIF expression and TNF-? and IL-8 secretion in THP-1 monocytes-derived macrophages.
Effect of chronic ethanol consumption in female rats subjected to experimental sepsis.
Effect of hypoxia on the expression of CCAAT/enhancer-binding protein ? and receptor activator of nuclear factor kappa-B ligand in periodontal ligament cells.
Effect of miR-29c on renal fibrosis in diabetic rats via the AMPK/mTOR signaling pathway.
Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease.
Effect of Trypanosoma brucei brucei on erythropoiesis in infected rats.
Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells.
Effects of oleanolic acid on pulmonary morphofunctional and biochemical variables in experimental acute lung injury.
Effects of whole body cryotherapy in patients with rheumatoid arthritis considering immune parameters.
Efficacy analysis of combined detection of 5 Serological Tumor markers including MIF and PIVKA-II for early diagnosis of Primary Hepatic Cancer.
Efficacy of bevacizumab combined with nedaplatin in the treatment of ovarian cancer and its effects on tumor markers and immunity of patients.
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
Elevated expression of transforming growth factor betas and the tumor necrosis factor family in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Emerging views of mitophagy in immunity and autoimmune diseases.
Endocrine and signalling role of adipose tissue: new perspectives on fat.
Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF.
Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation.
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models.
Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression.
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease.
Expression of inflammatory mediators in the otitis media induced by Helicobacter pylori antigen in mice.
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma.
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.
Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas.
Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.
Expression of mRNA for interleukin-1beta, interleukin-6, tumor necrosis factor-alpha and macrophage migration inhibitory factor in HPA-axis tissues in Schistosoma mansoni-infected baboons (Papio cynocephalus).
Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Functional variants of MIF, INFG and TFNA genes are not associated with disease susceptibility or hearing loss progression in patients with Ménière's disease.
Haplotypes of (-794(CATT)5-8/-173G>C) MIF gene polymorphisms and its soluble levels in basal cell carcinoma in western Mexican population.
High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
High-grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging.
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines.
Identification and Structure-Activity Relationships of Dietary Flavonoids as Human Macrophage Migration Inhibitory Factor (MIF) Inhibitors.
Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha.
Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts.
Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
Immunophenotyping of the cluster of differentiation 74, migration inhibitory factor, and cluster of differentiation 44 expression on human breast cancer-derived cell lines.
Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.
In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleaya cordata (Bo Luo Hui).
In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model.
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Induction of T-kininogen and tumor necrosis factor-alpha by macrophage migration inhibitory factor in vivo.
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link.
Inflammation driven tumor-like signaling in prostatic epithelial cells by sexually transmitted Trichomonas vaginalis.
Inflammation factors in hepatoblastoma and their clinical significance as diagnostic and prognostic biomarkers.
Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study.
Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.
Inflammatory cytokine-mediated induction of serine racemase in atopic dermatitis.
Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer.
Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population.
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Influence of molecular genetics in Vogt-Koyanagi-Harada disease.
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
Inhibition of Macrophage Migration Inhibitory Factor by a Chimera of Two Allosteric Binders.
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Insulin in sepsis and septic shock.
Insulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expression.
Insulin: an endogenous cardioprotector.
Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Interrelationship of Cytokines, Hypothalamic-Pituitary-Adrenal Axis Hormones, and Psychosocial Variables in the Prediction of Preterm Birth.
Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.
Involvement of CD74 in head and neck squamous cell carcinomas.
Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.
Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.
Is multiple sclerosis a proresolution deficiency disorder?
Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.
Kidney injury and alterations of inflammatory cytokine expressions in mice following long-term exposure to cerium chloride.
Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
KINSENOSIDE ISOLATED FROM ANOECTOCHILUS FORMOSANUS SUPPRESSES LIPOPOLYSACCHARIDE-STIMULATED INFLAMMATORY REACTIONS IN MACROPHAGES AND ENDOTOXIN SHOCK IN MICE.
Knockdown of D-dopachrome Tautomerase Inhibits Cell Proliferation in Human HepG2 Cell Line.
Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model.
Leptin Aggravates Reflux Esophagitis by Increasing Tissue Levels of Macrophage Migration Inhibitory Factor in Rats.
Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer.
Little evidence of systemic and adipose tissue inflammation in overweight individuals(†).
Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma.
Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC).
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF? in psoriatic arthritis.
Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer.
Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis.
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia.
Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation.
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator.
Macrophage migration inhibitory factor expression in cervical cancer.
Macrophage migration inhibitory factor in cancer.
Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells.
Macrophage migration inhibitory factor interacts with HBx and inhibits its apoptotic activity.
Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-?B activity.
Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome.
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells.
Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells.
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts.
Macrophage migration inhibitory factor modulates proliferation, cell cycle, and apoptotic activity in head and neck cancer cell lines.
Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer.
Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.
Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells.
Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF??B/HIF?1? pathway in lung cancer.
Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.
Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-?B signaling.
Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.
Macrophage Migration Inhibitory Factor-CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors.
Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy.
Macrophage migration inhibitory factor: a probable link between inflammation and cancer.
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.
Metabolic alterations and systemic inflammation in overweight/obese children with obstructive sleep apnea.
Metabolomic analysis coupled with extreme phenotype sampling identified that lysophosphatidylcholines are associated with multisite musculoskeletal pain.
Methylenetetrahydrofolate reductase C667T polymorphism is associated with increased risk of coronary artery disease in a Chinese population.
Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.
MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis.
MIF and TNF? serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma.
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models.
MIF promotes perineural invasion through EMT in salivary adenoid cystic carcinoma.
MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas.
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
MIF-Dependent Control of Tumor Immunity.
MIF: a key player in cutaneous biology and wound healing.
MIF: metastasis/MDSC-inducing factor?
miR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis.
Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles.
Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis.
mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action.
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Nanosecond Dynamics Regulate the MIF-Induced Activity of CD74.
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Newer uses of glucose-insulin-potassium regimen.
Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
Obesity, macrophage migration inhibitory factor, and weight loss.
Ontogeny of adipokine expression in neonatal pig adipose tissue.
Opposing roles of leptin and ghrelin in the equine corpus luteum regulation: an in vitro study.
Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
Osthole Attenuates Macrophage Activation in Experimental Asthma by Inhibitingthe NF-?B/MIF Signaling Pathway.
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.
Panel of markers can accurately predict endometriosis in a subset of patients.
Peroxisome Proliferator-Activated Receptor-gamma1 Gene Therapy Attenuates Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice.
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Plasma levels of IL-1Ra are associated with schizophrenia.
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Pleiotropic role of macrophage migration inhibitory factor in cancer.
Potential Role of Macrophage Migration Inhibitory Factor in the Pathogenesis of Marek's Disease.
Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer.
Primary study on the lesions and specific proteins in BEAS-2B cells induced with the 2009 A (H1N1) influenza virus.
Production of macrophage migration inhibitory factor by human and murine neuroblastoma.
Prognostic Implication of MIF Gene Expression in Childhood Acute Lymphoblastic Leukemia.
Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis.
Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.
Proliferation of NS0 cells in protein-free medium: the role of cell-derived proteins, known growth factors and cellular receptors.
Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters.
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells.
Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.
Psychological distress and SSRI use predict variation in inflammatory cytokines during pregnancy.
Pyrrolidine dithiocarbamate and dexamethasone are novel treatments of Acute Exogenous Lipoid Pneumonia.
Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model.
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice.
Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy.
Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.
Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
Role of macrophage migration inhibitory factor in paranasal sinus mucocele.
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice.
Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.
Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Signalling role of adipose tissue: adipokines and inflammation in obesity.
Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders.
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Structure-activity relationships for binding of 4-substituted triazole-phenols to macrophage migration inhibitory factor (MIF).
Studying the Pro-Migratory Effects of MIF.
Suppression of tumor growth through introduction of an antisense plasmid of macrophage migration inhibitory factor.
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer.
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
Targeting of interleukin-10 is superior to cytotoxic T-lymphocyte associated antigen 4 with human immunoglobulin G(1) for the prevention of chronic allograft deterioration in organ transplantation.
Targeting the heat shock protein 90: a rational way to inhibit macrophage migration inhibitory factor function in cancer.
Temporal regulation of the human immune system.
The Acute Liver Injury in Mice Caused by Nano-Anatase TiO(2).
The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis.
The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles.
The effects of spaceflight on mRNA levels for cytokines in proximal tibia of ovariectomized rats.
The expression of macrophage migration inhibitory factor in the non-small cell lung cancer.
The immunotoxicity of aluminum trichloride on rat peritoneal macrophages via ?2-adrenoceptors/cAMP pathway acted by norepinephrine.
The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis.
The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
The Mechanism of Liver Injury in Mice Caused by Lanthanoids.
The MIF -173G/C gene polymorphism increase gastrointestinal cancer and hematological malignancy risk: evidence from a meta-analysis and FPRP test.
The modulation of PCSK-9 and GAGs by 10-dehydrogingerdione and pentoxifylline in hyperlipidemic rabbits.
The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis.
The short-term efficacy of DEB-TACE loaded with epirubicin and raltitrexed in the treatment of intermediate and advanced primary hepatocellular carcinoma.
The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.
The vitamin D analogue paricalcitol attenuates hepatic ischemia/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats.
Therapeutic effects of daphnetin on adjuvant-induced arthritic rats.
Thioredoxin-1 suppresses systemic inflammatory responses against cigarette smoking.
TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs.
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).
Tumor growth-promoting properties of macrophage migration inhibitory factor.
Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes.
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB.
UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis.
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Urotensin II upregulates migration and cytokine gene expression in leukocytes of the African clawed frog, Xenopus laevis.
Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-?, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status.
[Increased cell migration of nasopharyngeal carcinoma cell lines in vitro by macrophage migration inhibitory factor]
[Inhibitory effect of emodin on the growth of cervical cancer in tumor-transplanted mice and underlying mechanism].
[Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis]
[The expression of ICAM-1 and cytokines in the reperfusional state]
[The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer]
[The study of serum complements and proinflammatory cytokines in sepsis rats].
Nephritis
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells.
Urinary Macrophage Migration Inhibitory Factor as a Noninvasive Biomarker in Pediatric Henoch-Schönlein Purpura Nephritis.
[Renal expression of macrophage migration inhibitory factor in children with Henoch-Sch-nlein purpura nephritis]
Nephrotic Syndrome
Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome.
Association of the macrophage migration inhibitory factor -173*C allele with childhood nephrotic syndrome.
Macrophage Migration Inhibitory Factor -173 G>C Gene Polymorphism Is Associated with Increased Risk of Nephrotic Syndrome in Children.
Nervous System Diseases
Adult astrocytes from reptiles are resistant to proinflammatory activation via sustaining Vav1 expression.
Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
Neuralgia
Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy.
Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury.
Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.
MIF mediates bladder pain, not inflammation, in cyclophosphamide cystitis.
Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity.
Vitamin E is a MIF Inhibitor.
Neuritis
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?
Neuritis, Autoimmune, Experimental
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?
Neuroblastoma
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
MicroRNA?451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor.
Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine.
Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma.
Production of macrophage migration inhibitory factor by human and murine neuroblastoma.
Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
Neurodegenerative Diseases
Discovery of Novel Inhibitors of the Tautomerase Activity of Macrophage Migration Inhibitory Factor (MIF).
Neurogenic Inflammation
Substance P induced release of macrophage migration inhibitory factor from rat bladder epithelium.
Neuroinflammatory Diseases
CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.
New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis.
Neurologic Manifestations
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Neurosyphilis
Macrophage migration inhibitory factor as a novel cerebrospinal fluid marker for neurosyphilis among HIV-negative patients.
Niemann-Pick Disease, Type C
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Niemann-Pick Diseases
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Non-alcoholic Fatty Liver Disease
Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Obesity
Advances in prognostic factors in acute pancreatitis: a mini-review.
Energy Expenditure Regulation Via Macrophage Migration Inhibitory Factor (MIF) in Obesity and In Vitro Anti-MIF Effect of Alpinia Officinarum Hance Extraction.
Impaired myocardial MIF/AMPK activation aggravates myocardial ischemia reperfusion injury in high-fat diet-induced obesity.
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women.
Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity.
Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis.
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.
Obesity, macrophage migration inhibitory factor, and weight loss.
Phenotyping of circulating extracellular vesicles (EVs) in obesity identifies large EVs as functional conveyors of Macrophage Migration Inhibitory Factor.
Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity.
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
Tautomerase Activity-Lacking of the Macrophage Migration Inhibitory Factor Alleviates the Inflammation and Insulin Tolerance in High Fat Diet-Induced Obese Mice.
The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.
Obesity, Abdominal
Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5?-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Obesity, Morbid
Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.
Optic Neuritis
CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
Orchitis
Cell-mediated and humoral immune responses to aspermatogenic antigen in experimental allergic orchitis in the guinea-pig.
Osteoarthritis
Deletion of Macrophage Migration Inhibitory Factor Reduces Severity of Osteoarthritis in Aged Mice.
Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
Secretory activity of subcutaneous abdominal adipose tissue in male patients with rheumatoid arthritis and osteoarthritis - association with clinical and laboratory data.
Osteoarthritis, Knee
Synovial Fluid Macrophage Migration Inhibitory Factor Levels Correlate with Severity of Self-Reported Pain in Knee Osteoarthritis Patients.
Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-?, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status.
Osteoporosis
Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Osteoporosis, Postmenopausal
[Role of macrophage migration inhibitory factor in pathogenesis of post-menopausal osteoporosis]
Osteosarcoma
A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF).
Differential expression of cytokines in rat osteosarcoma and malignant fibrous histiocytoma cell lines induced by 4-(hydroxyamino)quinoline-1-oxide.
Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.
Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
Otitis
Expression of macrophage migration inhibitory factor and CD74 in the inner ear and middle ear in lipopolysaccharide-induced otitis media.
Otitis Media
Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo.
Expression of macrophage migration inhibitory factor and CD74 in the inner ear and middle ear in lipopolysaccharide-induced otitis media.
Role of Macrophage Migration Inhibitory Factor in NLRP3 Inflammasome Expression in Otitis Media.
Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
Up-regulation of macrophage migration inhibitory factor induced by endotoxin in experimental otitis media with effusion in mice.
Otitis Media with Effusion
Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
Up-regulation of macrophage migration inhibitory factor induced by endotoxin in experimental otitis media with effusion in mice.
Out-of-Hospital Cardiac Arrest
Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest.
Ovarian Neoplasms
Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer.
Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer.
Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins.
Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Macrophage migration inhibitory factor expression in cervical cancer.
Macrophage migration inhibitory factor expression in ovarian cancer.
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer.
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Test of ovarian cancer multiplex xMAP technology panel.
Pain Insensitivity, Congenital
Lymphocyte TRPV 1-4 Gene Expression and MIF Blood Levels in a Young Girl Clinically Diagnosed With HSAN IV.
Pancreatic Neoplasms
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of beta-cell.
Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer.
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Pilot study of blood biomarker candidates for detection of pancreatic cancer.
Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer.
Pancreatitis
Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Different profiles of cytokine expression during mild and severe acute pancreatitis.
Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis.
Inhibition of macrophage migration inhibitory factor attenuates inflammation and fetal kidney injury in a rat model of acute pancreatitis in pregnancy.
Inhibition of macrophage migration inhibitory factor prevents thyroid dysfunction in pregnant rats with acute pancreatitis.
Macrophage migration inhibitory factor antagonist (S,R)3?(4?hydroxyphenyl)?4,5?dihydro?5?isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy.
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
Macrophage migration inhibitory factor is an early marker of severe acute pancreatitis based on the revised Atlanta classification.
Protective effect of chlorogenic acid on the inflammatory damage of pancreas and lung in mice with l-arginine-induced pancreatitis.
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer.
[Anti-cytokine therapy for severe acute pancreatitis]
Pancreatitis, Acute Necrotizing
Inhibition of macrophage migration inhibitory factor attenuates inflammation and fetal kidney injury in a rat model of acute pancreatitis in pregnancy.
Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Papillomavirus Infections
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Paramyxoviridae Infections
Emerging views of mitophagy in immunity and autoimmune diseases.
Parasitemia
A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Microbial translocation induces an intense proinflammatory response in visceral leishmaniasis patients co-infected with HIV-1.
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.
Parasitic Diseases
A computational assessment of the predicted structures of Human Macrophage Migration Inhibitory Factor 1 orthologs in parasites and its affinity to human CD74 receptor.
A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria.
MIF synergizes with Trypanosoma cruzi antigens to promote efficient dendritic cell maturation and IL-12 production via p38 MAPK.
Toxoplasma gondii: Impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection.
Parkinson Disease
Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease.
Macrophage Migration Inhibitory Factor Mediates Neuroprotective Effects by Regulating Inflammation, Apoptosis and Autophagy in Parkinson's Disease.
Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor.
Parkinsonian Disorders
Emerging views of mitophagy in immunity and autoimmune diseases.
Pemphigoid, Benign Mucous Membrane
Role of macrophage migration inhibitory factor in conjunctival pathology in ocular cicatricial pemphigoid.
Pemphigoid, Bullous
Macrophage migration inhibitory factor (MIF) in bullous pemphigoid.
Pemphigus
Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris.
Microphage migration inhibitory factor gene polymorphism is not associated with pemphigus vulgaris in Iranian patients.
Peptic Ulcer
Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases.
Periapical Periodontitis
Macrophage migration inhibitory factor gene polymorphisms as exacerbating factors of apical periodontitis.
Pericarditis
Macrophage migration inhibitory factor in rheumatoid pericarditis.
Periodontitis
Elevated Expression of Macrophage Migration Inhibitory Factor Promotes Inflammatory Bone Resorption Induced in a Mouse Model of Periradicular Periodontitis.
Expression profile of macrophage migration inhibitory factor in periodontitis.
The expression of macrophage migration inhibitory factor and intercellular adhesion molecule-1 in rats with periodontitis and atherosclerosis.
[Expression of SFRP1 and MIF in elderly patients with severe periodontitis and its correlation with cognitive function].
Peripheral Nerve Injuries
Changes in content of macrophage migration inhibitory factor secreted by Schwann cells after peripheral nerve injury.
[Expression of macrophage migration inhibitory factor mRNA in Schwann cells]
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency aggravates effects of fructose-enriched diet on lipid metabolism in the mouse liver.
Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Macrophage Migration Inhibitory Factor Deficiency Augments Cardiac Dysfunction in Type 1 Diabetic Murine Cardiomyocytes.
Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy.
Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation.
Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis.
Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.
Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation.
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis.
Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.
Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.
Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis.
Pituitary ACTH Hypersecretion
Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
Pituitary Neoplasms
Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
Pneumonia
Aggravation of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice Lacking Peroxiredoxin I.
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization.
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia.
The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.
Pneumonia, Pneumococcal
Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation.
Polychondritis, Relapsing
Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis.
Polycystic Kidney Diseases
Macrophage migration inhibitory factor is regulated by HIF-1? and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Polycystic kidney disease: Macrophage migration inhibitory factor regulates cyst growth in ADPKD.
Polycystic Kidney, Autosomal Dominant
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Polycystic kidney disease: Macrophage migration inhibitory factor regulates cyst growth in ADPKD.
Polycystic Ovary Syndrome
A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome.
Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.
Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.
Polymyositis
Roles of macrophage migration inhibitory factor in polymyositis: Inflammation and regeneration.
Post-Cardiac Arrest Syndrome
MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real life cohort.
Pre-Eclampsia
Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia.
Lower Macrophage Migration Inhibitory Factor Concentrations in Maternal Serum Before Pre-Eclampsia Onset.
Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia.
Maternal and umbilical cord blood level of macrophage migration inhibitory factor and insulin like growth factor in Sudanese women with preeclampsia.
Role of the Macrophage Migration Inhibitory Factor in the Pathophysiology of Pre-Eclampsia.
[Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].
[Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].
Precursor Cell Lymphoblastic Leukemia-Lymphoma
UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
Prediabetic State
Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes.
Pregnancy Complications
Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
Premature Birth
Differential patterns of 27 cord blood immune biomarkers across gestational age.
Prostatic Hyperplasia
The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling.
Prostatic Neoplasms
Bioinformatics Based Therapeutic Effects of Sinomenium Acutum.
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.
Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells.
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer.
Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence.
Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer.
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Serum macrophage migration inhibitory factor is not elevated in patients with prostate cancer.
Proteinuria
Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.
Protozoan Infections
Macrophage migration inhibitory factor (MIF): a key player in protozoan infections.
Macrophage migration inhibitory factor in protozoan infections.
Pruritus
Berberine induces anti-atopic dermatitis effects through the downregulation of cutaneous EIF3F and MALT1 in NC/Nga mice with atopy-like dermatitis.
Measurement of serum macrophage migration inhibitory factor (MIF) and correlation with severity and pruritus scores in client owned dogs with atopic dermatitis.
Psoriasis
Decreased Plasma Levels of Clusterin in Patients With Psoriasis.
Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.
High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis.
Histochemical analysis of macrophage migration inhibitory factor in psoriasis vulgaris.
Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis.
Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study.
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Protein phosphatase 2C?/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin.
Single-nucleotide polymorphism and haplotype analysis of macrophage migration inhibitory factor gene and its correlation with serum macrophage migration inhibitory factor levels in North Indian psoriatic patients with moderate disease severity: A cross-sectional study.
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Pulmonary Arterial Hypertension
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension.
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor ? in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
Pulmonary Disease, Chronic Obstructive
A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity.
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
Genetic regulation of gene expression of MIF family members in lung tissue.
Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.
Macrophage migration inhibitory factor, a role in COPD.
Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.
Prediction of sarcopenia using a battery of circulating biomarkers.
Progress in the mechanism and targeted drug therapy for COPD.
Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice.
[Electroacupuncture Improves Pulmonary Function of Rats with Chronic Obstructive Pulmonary Disease by Down-regulating Inflammatory Reaction and Expression of Macrophage Migration Inhibitory Factor/CD 74-CD 44/p 38 MAPK Signaling in Lung Tissues].
Pulmonary Fibrosis
Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats.
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
Purpura
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.
Lack of association between macrophage migration inhibitory factor gene promoter (-173 G/C) polymorphism and childhood Henoch-Schönlein purpura in Turkish patients.
Urinary Macrophage Migration Inhibitory Factor as a Noninvasive Biomarker in Pediatric Henoch-Schönlein Purpura Nephritis.
[Renal expression of macrophage migration inhibitory factor in children with Henoch-Sch-nlein purpura nephritis]
Purpura, Thrombocytopenic, Idiopathic
Polymorphism and expression of macrophage migration inhibitory factor does not contribute to glucocorticoid resistance in idiopathic thrombocytopenic purpura.
Pyelonephritis
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Renal Insufficiency, Chronic
Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.
Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease.
Reperfusion Injury
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: A predominant role of anti-inflammation.
Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.
Effects of macrophage migration inhibitory factor on cardiac reperfusion injury in mice with depression induced by constant-darkness.
The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.
Respiratory Distress Syndrome
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study.
Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis.
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome.
Role for macrophage migration inhibitory factor in acute respiratory distress syndrome.
[Effects of macrophage migration inhibitory factor in pathogenesis of acute respiratory distress syndrome in children]
[The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome]
Respiratory Distress Syndrome, Newborn
A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome.
Umbilical cord levels of macrophage migration inhibitory factor in neonatal respiratory distress syndrome
Respiratory Syncytial Virus Infections
Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages.
Rhabdomyosarcoma
Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma.
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts.
Rheumatic Diseases
Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.
Rheumatic Fever
Association of macrophage migration inhibitory factor and mannose-binding lectin-2 gene polymorphisms in acute rheumatic fever.
Rheumatic Heart Disease
Impact of MIF Gene Promoter Variations on Risk of Rheumatic Heart Disease and Its Age of Onset in Saudi Arabian Patients.
Rheumatoid Nodule
Detection of sarcolectin-specific receptors like the cytokine macrophage migration inhibitory factor in rheumatoid nodules.
Rheumatoid Vasculitis
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
Rhinitis, Allergic
Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis.
Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis.
Macrophage migration inhibitory factor in allergic rhinitis: its identification in eosinophils at the site of inflammation.
Sarcoidosis
Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.
Macrophage Migration Inhibitory Factor is not Associated with Sarcoidosis Susceptibility or Severity in Whites or Blacks.
Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis.
Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population.
Sarcoma
Macrophage migration inhibitory factor and stearoyl-CoA desaturase 1: potential prognostic markers for soft tissue sarcomas based on bioinformatics analyses.
Sarcopenia
Prediction of sarcopenia using a combination of multiple serum biomarkers.
Schistosomiasis mansoni
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Scleroderma, Diffuse
Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.
Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Scleroderma, Systemic
Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis.
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor ? in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.
Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.
Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.
Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis.
Seizures
Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise.
Sepsis
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.
A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.
A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis.
Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor.
Critical advances in septicemia and septic shock.
Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis.
Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.
Functional and prognostic relevance of -173 G/C gene polymorphism of macrophage migration inhibitory factor in sepsis patients in Egyptian intensive care units.
High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis.
High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor.
Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production.
Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality.
Insulin in sepsis and septic shock.
Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Lung-derived macrophage migration inhibitory factor in sepsis induces cardio-circulatory depression.
Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.
Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Macrophage migration inhibitory factor as a diagnostic and predictive biomarker in sepsis: meta-analysis of clinical trials.
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis.
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
Macrophage migration inhibitory factor induces cardiomyocyte apoptosis.
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
Macrophage migration inhibitory factor is associated with positive cultures in patients with sepsis after cardiac surgery.
Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis.
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis.
Macrophage migration inhibitory factor: controller of systemic inflammation.
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
MIF regulates innate immune responses through modulation of Toll-like receptor 4.
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Oxidoreductase Macrophage Migration Inhibitory Factor is simultaneously increased in leukocyte subsets of patients with severe sepsis.
Pathogenic bacteria and TNF do not induce production of macrophage migration inhibitory factor (MIF) by human monocytes.
Phenolic hydrazones are potent inhibitors of macrophage migration inhibitory factor proinflammatory activity and survival improving agents in sepsis.
Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis.
Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels.
Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor.
Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.
Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.
Role of macrophage migration inhibitory factor in glucocorticoid release and glucocorticoid receptor function in rats.
Small molecules in treatment of sepsis.
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
The cardioprotective effect of hypertonic saline is associated with inhibitory effect on macrophage migration inhibitory factor in sepsis.
The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae.
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity.
[Role of macrophage migration inhibitory factor in mice with sepsis and after effect of its intervention.]
[Role of macrophage migration inhibitory factor in systemic inflammatory response and development of sepsis]
Shock, Septic
Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.
Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock.
Critical advances in septicemia and septic shock.
Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization.
Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice.
Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Insulin in sepsis and septic shock.
Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.
Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity.
Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.
MIF as a glucocorticoid-induced modulator of cytokine production.
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Protection from septic shock by neutralization of macrophage migration inhibitory factor.
Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
Skin Diseases
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris.
Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease.
Macrophage migration inhibitory factor as an incriminating agent in vitiligo.
Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.
Skin Neoplasms
Expression and Function of Macrophage Migration Inhibitory Factor in the Pathogenesis of UV-Induced Cutaneous Nonmelanoma Skin Cancer(†).
Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC).
Tumour Microenvironment in Skin Carcinogenesis.
Sleep Apnea, Obstructive
Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea.
[The expression of macrophage migration inhibitory factor in obstructive sleep apnea hypopnea syndrome and its injury to endothelial cells].
Spinal Cord Injuries
Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice.
Elevated Circulating Levels of the Pro-Inflammatory Cytokine Macrophage Migration Inhibitory Factor in Individuals With Acute Spinal Cord Injury.
Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury.
Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review.
Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury.
Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury.
Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons.
Macrophage Migration Inhibitory Factor Promotes Chemotaxis of Astrocytes through Regulation of Cholesterol 25-Hydroxylase Following Rat Spinal Cord Injury.
Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury.
Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
[Effect of tetramethylpyrazine on the expression of macrophage migration inhibitory factor in acute spinal cord injury in rats].
[Identification of macrophage migration inhibitory factor (MIF) in rat spinal cord and its kinetics on experimental spinal cord injury]
Spondylitis, Ankylosing
Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia.
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor.
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis.
Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
MiR-451 suppresses inflammatory responses in ankylosing spondylitis by targeting macrophage migration inhibitory factor.
Squamous Cell Carcinoma of Head and Neck
HIF-?/MIF and NF-?B/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC.
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma.
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.
Starvation
Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy.
Still's Disease, Adult-Onset
A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.
Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.
The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Stomach Diseases
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Stomach Neoplasms
CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric Cancer.
Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis.
Gastric cancer susceptibility in gastric cancer relatives: Attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori.
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas.
Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.
microRNA-1228(?) impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor.
P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor.
The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer.
Stomach Ulcer
Gastric epithelial expression of macrophage migration inhibitory factor is not altered by Helicobacter pylori infection in humans.
Stomatitis
Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.
Stroke
Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.
Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke.
Hypoxia Signaling Regulates Macrophage Migration Inhibitory Factor (MIF) Expression in Stroke.
Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke.
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetes Patients With or Without Renal Dysfunction: Results from the ESTHER study.
Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.
Upregulation of macrophage migration inhibitory factor gene expression in stroke.
Stroke, Lacunar
Increased VEGF and Decreased SDF-1? in Patients with Silent Brain Infarction Are Associated with Better Prognosis after First-Ever Acute Lacunar Stroke.
Subarachnoid Hemorrhage
Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhage.
Macrophage migration inhibitory factor as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage.
The Association Between Serum Macrophage Migration Inhibitory Factor and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
Superinfection
Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.
Systemic Vasculitis
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.
Teratoma
MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation.
Thrombosis
Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population.
Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
Thyroiditis
Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.
Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.
Tonsillitis
Induction of macrophage migration inhibitory factor precedes the onset of acute tonsillitis.
Toxoplasmosis
Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
MIF participates in Toxoplasma gondii-induced pathology following oral infection.
MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.
NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection.
Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor.
WITHDRAWN: Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Toxoplasmosis, Congenital
Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis.
Trichinellosis
[Serum Levels of Macrophage Migration Inhibitory Factor and Leptin in Patients with Acute Trichinellosis.]
Triple Negative Breast Neoplasms
Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Tuberculosis
Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population.
CATT polymorphism in MIF gene promoter is closely related to human pulmonary tuberculosis in a southwestern China population.
Correlation between genetic susceptibility of tuberculosis and macrophage migration inhibitory factor.
Increased density of macrophage migration inhibitory factor (MIF) in tuberculosis granuloma.
Low expression Macrophage Migration Inhibitory Factor (MIF) alleles and tuberculosis in HIV infected South Africans.
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.
Macrophage migration inhibitory factor -173 G > C polymorphism and risk of tuberculosis: A meta-analysis.
Macrophage migration inhibitory factor -?794 CATT5-8 microsatellite polymorphism and susceptibility of tuberculosis.
Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population.
Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages.
MIF -173 G?>?C (rs755622) Gene Polymorphism Modulates Tuberculosis Risk: Evidence from a Meta-analysis and Trial Sequential Analysis.
Single nucleotide polymorphisms in cytokine MIF gene promoter region are closely associated with human susceptibility to tuberculosis in a southwestern province of China.
Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis.
Tuberculosis, Pulmonary
Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population.
Association between the MIF-173G/C Polymorphism and Serum MIF levels with Pulmonary Tuberculosis: A Meta-analysis.
Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis.
Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.
Macrophage migration inhibitory factor -173 G>C single nucleotide polymorphism and its association with active pulmonary tuberculosis.
Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis.
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis.
Urinary Bladder Neck Obstruction
Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.
Urinary Bladder Neoplasms
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells.
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
Urinary Tract Infections
Macrophage Migration Inhibitory Factor is Increased in the Urine of Patients With Urinary Tract Infection: Macrophage Migration Inhibitory Factor-Protein Complexes in Human Urine.
Urinary macrophage migration inhibitory factor in children with urinary tract infection.
Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Uterine Cervical Neoplasms
Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis.
KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
Macrophage migration inhibitory factor expression in cervical cancer.
Macrophage migration inhibitory factor promoter polymorphisms (-794CATT5-7 ) as potential biomarker for early-stage cervical cancer.
[Expression of MIF, VEGF and p16 proteins and their correlation with clinicopathological features in cervical cancer]
Uveitis
Macrophage migration inhibitory factor in ocular fluids of patients with uveitis.
Macrophage migration inhibitory factor in uveitis.
Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with Notch signaling in experimental autoimmune uveitis.
Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Vaccinia
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
Vascular Diseases
Evidence for a role of macrophage migration inhibitory factor in vascular disease.
Intertwining of thrombosis and inflammation in atherosclerosis.
Vascular System Injuries
Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
Vasculitis
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.
Macrophage migration inhibitory factor (MIF) and thyroid hormone alterations in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides.
Role of macrophage migration inhibitory factor in granulomatosis with polyangiitis.
Vasculitis, Leukocytoclastic, Cutaneous
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.
Vasospasm, Intracranial
Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhage.
Vertigo
Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.
Virus Diseases
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages.
Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.
Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability.
Macrophage Migration Inhibitory Factor Triggers Inflammatory Responses During Very Virulent Infectious Bursal Disease Virus Infection.
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection.
Vitiligo
Macrophage migration inhibitory factor as an incriminating agent in vitiligo.
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease.
Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.
Soluble CD27 and MIF as possible serum biomarkers of vitiligo activity in Egyptian patients in Sharkia Governorate.
Vitreoretinopathy, Proliferative
Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Warts
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris.
Possible role of interleukin-17 and macrophage migration inhibitory factor in cutaneous warts.
Wiskott-Aldrich Syndrome
Production of macrophage migration inhibitory factor and lymphotoxin by leukocytes from normal and Wiskott-Aldrich syndrome patients.
Zika Virus Infection
An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection.